Amyloid imaging in cognitively normal individuals, at-risk populations and preclinical Alzheimer's disease

被引:271
作者
Chetelat, Gael [1 ,2 ,3 ,4 ]
La Joie, Renaud [1 ,2 ,3 ,4 ]
Villain, Nicolas [1 ,2 ,3 ,4 ]
Perrotin, Audrey [1 ,2 ,3 ,4 ]
de La Sayette, Vincent [1 ,2 ,3 ,4 ,5 ]
Eustache, Francis [1 ,2 ,3 ,4 ]
Vandenberghe, Rik [6 ,7 ,8 ]
机构
[1] INSERM, U1077, Caen, France
[2] Univ Caen Basse Normandie, UMR S1077, Caen, France
[3] Ecole Prat Hautes Etud, UMR S1077, Caen, France
[4] CHU Caen, U1077, F-14000 Caen, France
[5] CHU Caen, Serv Neurol, F-14000 Caen, France
[6] Univ Leuven, Dept Neurosci, Lab Cognit Neurol, Leuven, Belgium
[7] Univ Hosp Leuven, Dept Neurol, Leuven, Belgium
[8] Univ Leuven, KU Leuven, Alzheimer Res Ctr, Leuven Inst Neurosci & Dis, Leuven, Belgium
关键词
Amyloid PET imaging; Cognitively normal elderly; Preclinical Alzheimer's disease; Subjective cognitive decline; ApoE4; Longitudinal studies; POSITRON-EMISSION-TOMOGRAPHY; FLORBETAPIR F 18; BETA-PEPTIDE DEPOSITION; NORMAL OLDER-ADULTS; ASSOCIATION WORKGROUPS; DIAGNOSTIC GUIDELINES; NATIONAL INSTITUTE; MEMORY PERFORMANCE; FAMILY-HISTORY; GENETIC RISK;
D O I
10.1016/j.nicl.2013.02.006
中图分类号
R445 [影像诊断学];
学科分类号
100207 ;
摘要
Recent developments of PET amyloid ligands have made it possible to visualize the presence of A beta deposition in the brain of living participants and to assess the consequences especially in individuals with no objective sign of cognitive deficits. The present review will focus on amyloid imaging in cognitively normal elderly, asymptomatic at-risk populations, and individuals with subjective cognitive decline. It will cover the prevalence of amyloid-positive cases amongst cognitively normal elderly, the influence of risk factors for AD, the relationships to cognition, atrophy and prognosis, longitudinal amyloid imaging and ethical aspects related to amyloid imaging in cognitively normal individuals. Almost ten years of research have led to a few consensual and relatively consistent findings: some cognitively normal elderly have A beta deposition in their brain, the prevalence of amyloid-positive cases increases in at-risk populations, the prognosis for these individuals is worse than for those with no A beta deposition, and significant increase in A beta deposition over time is detectable in cognitively normal elderly. More inconsistent findings are still under debate; these include the relationship between A beta deposition and cognition and brain volume, the sequence and cause-to-effect relations between the different AD biomarkers, and the individual outcome associated with an amyloid positive versus negative scan. Preclinical amyloid imaging also raises important ethical issues. While amyloid imaging is definitely useful to understand the role of A beta in early stages, to define at-risk populations for research or for clinical trial, and to assess the effects of anti-amyloid treatments, we are not ready yet to translate research results into clinical practice and policy. More researches are needed to determine which information to disclose from an individual amyloid imaging scan, the way of disclosing such information and the impact on individuals and on society. (C) 2013 The Authors. Published by Elsevier Inc.
引用
收藏
页码:356 / 365
页数:10
相关论文
共 119 条
  • [1] Frequent Amyloid Deposition Without Significant Cognitive Impairment Among the Elderly
    Aizenstein, Howard Jay
    Nebes, Robert D.
    Saxton, Judith A.
    Price, Julie C.
    Mathis, Chester A.
    Tsopelas, Nicholas D.
    Ziolko, Scott K.
    James, Jeffrey A.
    Snitz, Beth E.
    Houck, Patricia R.
    Bi, Wenzhu
    Cohen, Ann D.
    Lopresti, Brian J.
    DeKosky, Steven T.
    Halligan, Edythe M.
    Klunk, William E.
    [J]. ARCHIVES OF NEUROLOGY, 2008, 65 (11) : 1509 - 1517
  • [2] The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
    Albert, Marilyn S.
    DeKosky, Steven T.
    Dickson, Dennis
    Dubois, Bruno
    Feldman, Howard H.
    Fox, Nick C.
    Gamst, Anthony
    Holtzman, David M.
    Jagust, William J.
    Petersen, Ronald C.
    Snyder, Peter J.
    Carrillo, Maria C.
    Thies, Bill
    Phelps, Creighton H.
    [J]. ALZHEIMERS & DEMENTIA, 2011, 7 (03) : 270 - 279
  • [3] Subjective cognitive complaints and amyloid burden in cognitively normal older individuals
    Amariglio, Rebecca E.
    Becker, J. Alex
    Carmasin, Jeremy
    Wadsworth, Lauren P.
    Lorius, Natacha
    Sullivan, Caroline
    Maye, Jacqueline E.
    Gidicsin, Christopher
    Pepin, Lesley C.
    Sperling, Reisa A.
    Johnson, Keith A.
    Rentz, Dorene M.
    [J]. NEUROPSYCHOLOGIA, 2012, 50 (12) : 2880 - 2886
  • [4] [Anonymous], 1968, PUBLIC HLTH PAP, DOI DOI 10.1001/ARCHINTE.1969.00300130131020
  • [5] Amyloid load and cerebral atrophy in Alzheimer's disease:: An 11C-PIB positron emission tomography study
    Archer, Hilary A.
    Edison, Paul
    Brooks, David J.
    Barnes, Jo
    Frost, Chris
    Yeatman, Toni
    Fox, Nick C.
    Rossor, Martin N.
    [J]. ANNALS OF NEUROLOGY, 2006, 60 (01) : 145 - 147
  • [6] Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease
    Bateman, Randall J.
    Xiong, Chengjie
    Benzinger, Tammie L. S.
    Fagan, Anne M.
    Goate, Alison
    Fox, Nick C.
    Marcus, Daniel S.
    Cairns, Nigel J.
    Xie, Xianyun
    Blazey, Tyler M.
    Holtzman, David M.
    Santacruz, Anna
    Buckles, Virginia
    Oliver, Angela
    Moulder, Krista
    Aisen, Paul S.
    Ghetti, Bernardino
    Klunk, William E.
    McDade, Eric
    Martins, Ralph N.
    Masters, Colin L.
    Mayeux, Richard
    Ringman, John M.
    Rossor, Martin N.
    Schofield, Peter R.
    Sperling, Reisa A.
    Salloway, Stephen
    Morris, John C.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (09) : 795 - 804
  • [7] Amyloid-β Associated Cortical Thinning in Clinically Normal Elderly
    Becker, J. Alex
    Hedden, Trey
    Carmasin, Jeremy
    Maye, Jacqueline
    Rentz, Dorene M.
    Putcha, Deepti
    Fischl, Bruce
    Greve, Douglas N.
    Marshall, Gad A.
    Salloway, Stephen
    Marks, Donald
    Buckner, Randy L.
    Sperling, Reisa A.
    Johnson, Keith A.
    [J]. ANNALS OF NEUROLOGY, 2011, 69 (06) : 1032 - 1042
  • [8] Berti V, 2011, Q J NUCL MED MOL IM, V55, P225
  • [9] Is it time for biomarker-based diagnostic criteria for prodromal Alzheimer's disease?
    Blennow, Kaj
    Zetterberg, Henrik
    [J]. ALZHEIMERS RESEARCH & THERAPY, 2010, 2 (02):
  • [10] β-Amyloid burden in the temporal neocortex is related to hippocampal atrophy in elderly subjects without dementia
    Bourgeat, P.
    Chetelat, G.
    Villemagne, V. L.
    Fripp, J.
    Raniga, P.
    Pike, K.
    Acosta, O.
    Szoeke, C.
    Ourselin, S.
    Ames, D.
    Ellis, K. A.
    Martins, R. N.
    Masters, C. L.
    Rowe, C. C.
    Salvado, O.
    Grp, A. I. B. L. Res
    [J]. NEUROLOGY, 2010, 74 (02) : 121 - 127